A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines
- 1 November 2010
- journal article
- research article
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 25 (6) , 349-355
Abstract
Although no psychotropic agents are specifically licensed for the management of borderline personality disorder (BPD), pharmacological treatment appears to be common. This study aimed to examine the drug prescriptions for patients with BPD in clinical practice, analyze the prescription patterns from the appearance of the American Psychiatric Association guidelines in 2001 until the National Institute for Health and Clinical Excellence guidelines in 2009, and identify the factors associated with such prescription of each type of drug. Naturalistic study on 226 consecutive BPD patients admitted to an outpatient BPD program. Socio-demographic, clinical and pharmacological treatment information was collected; factors associated with drug prescription were examined using logistic regression analyses for dichotomous outcomes measures. Changes in prescription patterns over time were also evaluated. Patients received an average of 2.7 drugs; only 6% were drug-free; 56% were taking ≥3 drugs and 30% ≥4 drugs. Over the past 8 years, prescription of antidepressants has remained stable; there has been a significant reduction in prescription of benzodiazepines and an increase in the use of mood stabilizers and atypical antipsychotics. Comorbidity with Axis I disorders was the main factor associated with drug prescription. Drug prescription and polypharmacy are common in the management of BPD in clinical practice.Keywords
This publication has 17 references indexed in Scilit:
- Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trialsThe British Journal of Psychiatry, 2010
- Effectiveness of Pharmacotherapy for Severe Personality DisordersThe Journal of Clinical Psychiatry, 2009
- Hospitalization and Pharmacotherapy for Borderline Personality Disorder in a Psychiatric Emergency ServicePsychiatric Services, 2007
- Topiramate Treatment for Women With Borderline Personality DisorderJournal of Clinical Psychopharmacology, 2006
- Treatment of aggression with topiramate in male borderline patients: A double-blind, placebo-controlled studyBiological Psychiatry, 2005
- Topiramate Treatment of Aggression in Female Borderline Personality Disorder PatientsThe Journal of Clinical Psychiatry, 2004
- SSRI Treatment of Borderline Personality Disorder: A Randomized, Placebo-Controlled Clinical Trial for Female Patients With Borderline Personality DisorderAmerican Journal of Psychiatry, 2002
- Treatment Utilization by Patients With Personality DisordersAmerican Journal of Psychiatry, 2001
- Fluoxetine and Impulsive Aggressive Behavior in Personality-Disordered SubjectsArchives of General Psychiatry, 1997
- The Diagnosis of Personality Disorder With a Modified Version of the SCID-II in A Spanish Clinical SampleJournal of Personality Disorders, 1994